2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this program brings together a distinguished team of thought leaders in genitourinary cancers to present the latest strategies for managing localized and advanced bladder, kidney, and prostate cancers.
With rapid advances in systemic therapies, surgical techniques, and radiation technologies, clinicians are navigating an increasingly complex treatment landscape. The rapid entry of novel agents into the non-muscle invasive bladder cancer space is creating new therapeutic decision points. At the same time, advances in radiation oncology technologies and techniques continue to refine precision and efficacy. This CME program focuses on how to effectively integrate these innovations into everyday practice.
Through expert-led lectures, panel discussions, and case-based sessions, participants will gain practical insights they can apply directly in the clinical trenches.
Peri-operative Muscle-Invasive Bladder Cancer (MIBC) Management
Updates in Metastatic Castration-Resistant Prostate Cancer (mCRPC)


